Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: quality-of-life assessment
Sponsor: Eastern Cooperative Oncology Group
Collaborators: National Cancer Institute (NCI)|NCIC Clinical Trials Group